BlackRock Group’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.8M Buy
203,852
+69,983
+52% +$629K ﹤0.01% 1835
2016
Q3
$1.15M Sell
133,869
-534
-0.4% -$4.23K ﹤0.01% 1958
2016
Q2
$1.07M Buy
134,403
+21,191
+19% +$165K ﹤0.01% 1936
2016
Q1
$990K Buy
113,212
+8,682
+8% +$72.1K ﹤0.01% 1950
2015
Q4
$980K Sell
104,530
-4,242
-4% -$36.8K ﹤0.01% 1912
2015
Q3
$1.05M Sell
108,772
-9,703
-8% -$102K ﹤0.01% 1851
2015
Q2
$1.37M Buy
118,475
+97,306
+460% +$1M ﹤0.01% 1766
2015
Q1
$221K Buy
21,169
+10,483
+98% +$98.1K ﹤0.01% 2469
2014
Q4
$123K Buy
+10,686
New +$106K ﹤0.01% 2631

Other funds holding MDXG

BlackRock Group's MDXG Position: Q4 2016 in Review

BlackRock Group increased its MiMedx Group (MDXG) stake by 52% in Q4 2016, buying an estimated $629K and bringing the position to 203,852 shares worth $1.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1835.

BlackRock Group first reported a position in MDXG in Q4 2014 and has held it in 9 quarters since. 185 funds tracked by Wall St. Rank hold MDXG as of Q4 2016.

  • BlackRock Group held 203,852 shares of MiMedx Group worth $1.8M as of Q4 2016.
  • BlackRock Group bought 69,983 MiMedx Group shares in Q4 2016, an estimated $629K.
  • MiMedx Group made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1835 holding.
  • BlackRock Group first reported a position in MiMedx Group in Q4 2014 and has held it in 9 quarters since.
  • 185 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.